What is the success rate of stem cell therapy for Peripheral Neuropathy?
No universal success rate exists. Neuropathy causes and outcomes differ; review the exact diagnosis, objective nerve and functional measures, pain outcomes, comparator, concurrent treatment, adverse events, denominators and full follow-up.
What the evidence shows for Peripheral Neuropathy
The diagnosis should define nerve type, distribution, cause and severity before any experimental product is considered. Studies must match the exact neuropathy, product, route, comparator and validated pain, sensory, motor and functional outcomes. FDA patient information states that regenerative medicine products marketed for neurological conditions require product-level review and warns of serious harms from unapproved products. Do not transfer evidence from spinal cord injury, diabetic ulcers or another neuropathy.
Am I a candidate? → · Peripheral Neuropathy: full overview → · Peripheral Neuropathy cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.
Sources & further reading
More on this condition
- Peripheral Neuropathy: cell-therapy evidence and registered trials
- How much does stem cell therapy for Peripheral Neuropathy cost? (2026)
- Peripheral Neuropathy stem cell therapy — your questions answered (2026)
- Peripheral Neuropathy: cell-therapy evidence by therapy class
- MSC vs PRP for Peripheral Neuropathy: what the registries show